Literature DB >> 11242193

Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue.

A H Talal1, C E Irwin, D T Dieterich, H Yee, L Zhang.   

Abstract

OBJECTIVE: To determine the change in the percentage of proliferative and activated lymphocytes in gut-associated lymphoid tissue (GALT) in HIV-1-infected subjects compared with that in uninfected controls.
METHODS: We measured the percentage of proliferative (Ki-67+) and activated (CD-69+, HLA-DR+, CD45RO+) lymphocytes from GALT and peripheral blood in chronically HIV-1-infected (12) and uninfected (9) individuals.
RESULTS: The percentage of proliferative GALT CD4+ T cells was increased in HIV-1-infected control subjects compared with that in uninfected controls (p <.007). Based on immunohistochemical staining, proliferative T cells were principally located in the parafollicular area surrounding lymphoid aggregates. The percentage of activated GALT lymphocytes, however, was not significantly different in HIV-1-infected individuals, whereas it was significantly increased in the peripheral blood of HIV-1-infected individuals. The percentage of peripheral blood lymphocytes trafficking to the intestine was also not significantly different in HIV-1-infected individuals compared with that in uninfected controls.
CONCLUSIONS: CD4+ T cell proliferation in GALT is increased in HIV-1 infection without a significant alteration in the percentage of peripheral blood T cells trafficking to the gastrointestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242193     DOI: 10.1097/00042560-200103010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

1.  CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.

Authors:  A W Lin; S A Gonzalez; S Cunningham-Rundles; G Dorante; S Marshall; A Tignor; C Ha; I M Jacobson; A H Talal
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  Preliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody.

Authors:  L E Pereira; N Onlamoon; X Wang; R Wang; J Li; K A Reimann; F Villinger; K Pattanapanyasat; K Mori; A A Ansari
Journal:  Cell Immunol       Date:  2009-06-26       Impact factor: 4.868

Review 3.  Decimated or missing in action: CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection.

Authors:  Anthony D Kelleher; John J Zaunders
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

4.  Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.

Authors:  Nathalia Holt; Jianbin Wang; Kenneth Kim; Geoffrey Friedman; Xingchao Wang; Vanessa Taupin; Gay M Crooks; Donald B Kohn; Philip D Gregory; Michael C Holmes; Paula M Cannon
Journal:  Nat Biotechnol       Date:  2010-07-02       Impact factor: 54.908

5.  The Spontaneous Control of HIV Replication is Characterized by Decreased Pathological Changes in the Gut-associated Lymphoid Tissue.

Authors:  Natalia A Taborda; Luis A Correa; Manuel Geronimo Feria; María T Rugeles
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.